OUR PRODUCTS

MOBILE APPS

GENERAL INFO

SPRO

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Spero Therapeutics (SPRO) Earnings Date & Reports

Spero Therapeutics Inc is a clinical-stage biopharmaceutical firm... Show more

Industry: #Pharmaceuticals Major

Get AI intraday signals

A.I. Advisor

published Earnings

SPRO is expected to report earnings to rise 128.00% to -56 cents per share on August 12

Spero Therapeutics SPRO Stock Earnings Reports

Q2'25

Est.

$-0.57

Q1'25

Beat

by $0.02

Q4'24

Missed

by $0.02

Q3'24

Beat

by $0.18

Q2'24

Beat

by $0.05

The last earnings report on May 13 showed earnings per share of -25 cents, beating the estimate of -27 cents. With 188.20K shares outstanding, the current market capitalization sits at 122.44M.

View a ticker or compare two or three

Compare

SPRO

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For SPRO
(Try 14 days for Free)

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. SPRO showed earnings on May 13, 2025. You can read more about the earnings report here.

View AI-Driven Trading

A.I. Advisor

published General Information

General Information

a developer of novel therapies for the treatment of resistant bacterial infections

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Pharmaceuticals Major

Address

675 Massachusetts Avenue

Phone

+1 857 242-1600

Employees

Web

https://www.sperotherapeutics.com